Leading ICR scientists receive RCR recognition

Institute of Cancer Research scientists Professor Nick James and Professor Emma Hall have been recognised for their contributions to radiology and oncology by The Royal College of Radiologists.

Professor James was awarded the RCR Gold Medal for his contribution to treatment of prostate and bladder cancer and to patient education. This is the highest honour the RCR can bestow and is awarded to an esteemed fellow of the college who has made a significant contribution in their field, whether in the UK or overseas. Professor James leads the prostate and bladder cancer research team and is ICR deputy dean, clinical studies, and consultant oncologist at The Royal Marsden NHS Foundation Trust. He is a clinical academic who seeks to improve patient outcomes through large scale clinical trials. His work focuses on bladder and prostate cancer, with a strong emphasis on novel trial design.

Professor Hall was given an Honorary Membership, which is awarded to those who have promoted the interests of clinical radiology or clinical oncology and made notable contributions to either. Deputy director of the Cancer Research UK-funded Clinical Trials and Statistics Unit, Professor Hall leads the radiotherapy, urology and head and neck cancers trials team. She is a medical statistician with a particular interest in clinical trials that aim to improve the treatment of urological and head and neck cancers. Professor Hall has been methodology lead on many influential clinical trials. One of those, the CHHiP radiotherapy trial, demonstrated the effectiveness of a new radiotherapy regime for prostate cancer that involved fewer but higher doses of radiation. She is a member of the National Clinical Research Institute’s bladder and renal cancers research group and its clinical and translational radiotherapy research group.

Picture: Professor Emma Hall and Professor Nick James.

Published on page 2 of the July 2021 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more